TD Securities resumed coverage of Docebo (DCBO) with a Buy rating and $37 price target
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DCBO:
- Docebo’s Earnings Call Highlights Strategic Growth and Challenges
- Docebo price target raised to $46 from $43 at Canaccord
- Docebo Reports Strong Q2 2025 Financial Results
- Optimistic Buy Rating for Docebo Amid Strong Performance and Innovative Growth Prospects
- Docebo reports Q2 adjusted EPS 29c, consensus 22c